Sector IntelligenceZug

VALUATION DIAGNOSTIC
MedTech & Medical Devices

Specific market analysis for MedTech & Medical Devices companies based in Zug.

Pro-Forma Valuation

Market demand in Zug for MedTech & Medical Devices assets remains strong.

KEY DRIVER

"Skills gap, continuous professional development (CPD)."

Local Multiples (Est.)

6.0 - 8.5x Statutory

Get Your Report

Generate a certified valuation for your MedTech & Medical Devices business in Zug.

Start Valuation

Valuation Impact by Size (DACH 2025)

Size BucketMultiple RangeImpact
Micro (< CHF 1M EBITDA)3.8x - 5.1x-33.3%
Small (CHF 1M - 2M EBITDA)5.2x - 7.1x-6.7%
Transition (CHF 2M - 5M EBITDA)6.4x - 8.6x+11.1%
Lower Mid-Market (CHF 5M - 10M EBITDA)8.7x - 11.8x+33.3%
Mid-Market (> CHF 10M EBITDA)11.0x - 14.9x+66.7%

Source: NIMBO, Dealsuite, KPMG, SECA, Practitioner Interviews // Niche Baseline: 7.5x

MedTech & Medical Devices Market in Zug

Zug — known for its status as Crypto Valley, numerous global headquarters, a favorable tax environment — represents a significant market for MedTech & Medical Devices companies in Switzerland. The local business environment is shaped by the canton's economic profile, offering distinct opportunities for both buyers and sellers in this niche.

Current EBITDA multiples for MedTech & Medical Devices businesses range from 6.0 - 8.5x (statutory) to 6.5 - 10.5x (deal), reflecting a significant arbitrage opportunity. The sector trend is rising, driven by: Skills gap, continuous professional development (CPD). This positions Zug as a notable market within the broader Healthcare sector.

ZugEconomy Snapshot

Corporate Tax
11.9%
#1/26
Companies
20'500
98.8% SME
Unemployment
1.7%
Median Salary
CHF 7'800
/month
Succession Risk
28%
owners 55+

Why MedTech & Medical Devices in Zug?

Zug offers a diversified economic base with 20'500 total companies. While not a primary hub for MedTech & Medical Devices, the canton's competitive tax environment and skilled workforce create favorable conditions for business operations and valuations.

  • Switzerland's lowest corporate tax rate at 11.9% with minimal personal income taxation, creating an unmatched fiscal advantage
  • World-renowned 'Crypto Valley' ecosystem making Zug Europe's leading hub for blockchain, digital assets, and fintech innovation
  • Extraordinary concentration of multinational headquarters and commodity-trading firms driving high-value economic activity

Tax Impact on Valuation

At Zug's effective corporate tax rate of 11.9% (rank #1/26), after-tax EBITDA retention is 88.1%. This directly influences enterprise valuations and buyer economics in the MedTech & Medical Devices sector.

FAQ: MedTech & Medical Devices in Zug

How many MedTech & Medical Devices companies are in Zug?

Zug has 20'500 total companies. Specific MedTech & Medical Devices company counts are part of the broader industrial landscape.

What is the corporate tax rate in Zug?

The effective corporate tax rate in Zug is 11.9%, ranking #1 among Switzerland's 26 cantons.

What are MedTech & Medical Devices valuation multiples in Zug?

Current statutory EBITDA multiples for MedTech & Medical Devices range from 6.0 - 8.5x. Deal-based multiples are 6.5 - 10.5x. These are influenced by Zug's tax environment and local market conditions.

What is the business succession outlook in Zug?

While Zug's succession challenge is proportionally less acute than in more rural cantons -- with 28% of owners over 55 versus 35-38% in Glarus or Obwalden -- the absolute numbers are significant given the canton's large company base. Many of Zug's succession-relevant companies are in traditional SME sectors such as construction, retail, and professional services, coexisting alongside the highly dynamic startup and multinational ecosystem. The deep advisory infrastructure and active M&A market in Zug mean that succession solutions are more readily available than in smaller cantons.

Explore all industries in Zug

Canton hub: tax data, industry composition, key employers

View Complete MedTech & Medical Devices National Overview →

Full Swiss market analysis across all 26 cantons, including comparable M&A transactions and sector trends.